An Open-Label, Phase 1 Study in Healthy Adult Subjects to Examine the Effects of Multiple-Dose Ciprofloxacin on Ivacaftor and VX-661 in Combination With Ivacaftor
Clinical trial NCT02015507 · COMPLETED
Trial details
- NCT number
- NCT02015507
- Sponsor
- Vertex Pharmaceuticals Incorporated
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-01-01
- Primary completion
- 2014-02-01
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.